Presepsin (Soluble CD14 Subtype) as an Early Marker of Neonatal Sepsis and Septic Shock: A Prospective Diagnostic Trial.

Antibiotics (Basel) · 2021 · PMC8156848 · PMID 34068959

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

Introduction Despite a favorable trend over the last two decades, neonatal sepsis is still a major cause of morbidity, mortality, and antibiotic use among neonates, with an incidence of 1–4 per 1000 live births rising up to 12–17% in very low birth weight infants (VLBWi) [ 1 ].

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.